United States: Eli Lilly is investing $3 billion to expand its recently acquired plant in Pleasant Prairie, Wisconsin. This significant expansion aims to address the soaring demand for its weight-loss medication Zepbound and diabetes treatment Mounjaro (tirzepatide). Lilly acquired the ...